Target intelligence / Profile preview

Activator protein-1 transcription factor subunit Jun (JUN)

Target
JUN
Molecular classification
Transcription factor, Basic-region leucine zipper (bZIP) protein family
01

Overview

Activator protein-1 (AP-1) is a dimeric transcription factor complex primarily formed by proteins of the JUN (e.g., c-Jun, JunB, JunD) and FOS (e.g., c-Fos, FosB, Fra-1, Fra-2) families that share a basic-region leucine zipper (bZIP) domain, enabling specific DNA binding and dimerization. The AP-1 transcription factor regulates numerous genes involved in cell proliferation, differentiation, apoptosis, and response to stress. c-Jun is a major component of AP-1 and can form homodimers or heterodimers (most often with FOS family proteins), which then bind DNA at consensus response elements to regulate expression of target genes. Aberrant AP-1/JUN activity is implicated in oncogenesis, cancer progression, inflammation, and cardiovascular disease. Therapeutic modulation of AP-1/JUN is of interest for cancer and chronic inflammatory conditions, but such interventions face significant challenges due to the pleiotropic and context-dependent nature of AP-1 functions in normal and pathological processes[1][2][3][5].

Other names
AP-1 (when referring to the dimeric complex)c-JunJunJun proto-oncogeneJun/AP-1JUN (gene/protein)Transcription factor AP-1 subunit Jun
02

Mechanism of action

Inhibition of AP-1/JUN DNA binding (prevents recruitment to target gene promoters); Suppression of JUN/FOS dimer formation; Downregulation of c-Jun/JUN expression or protein stability; Inhibition of upstream kinases (e.g., JNK) that phosphorylate and activate JUN

03

Biological functions

Regulation of gene expressionCell proliferationDelineationApoptosisCell cycle controlCellular stress response
04

Disease associations

CancerInflammationCardiovascular disease (notably cardiac remodeling)Other diseases associated with dysregulated proliferation or apoptosis
05

Safety considerations

On-target toxicity due to broad role in regulation of proliferation, apoptosis, and differentiationPotential for adverse effects in tissues reliant on AP-1 for homeostasis (e.g., skin, immune system, cardiac tissue)Risk of impaired tissue repair or development
06

Interacting drugs

Curcumin (a polyphenol with multiple biological activities including direct inhibition of AP-1 activity)

2 more in the full profile.

07

Biomarkers

c-Jun/JUN expression levels (tissue, tumor biopsy)Phosphorylated JUN (p-JUN)Activity of AP-1 reporter genes or target gene expression signatures

Beyond the preview

Go deeper on Activator protein-1 transcription factor subunit Jun (JUN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activator protein-1 transcription factor subunit Jun (JUN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call